Lirum Therapeutics
PrivateLast Round
IPO
Mar 11, 2024
Est. Valuation
$45M
Company Overview
Lirum Therapeutics is a clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lirum Therapeutics Comparables
Compare Lirum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sling Therapeutics | 83% | |
| Astellas Pharma Inc. | 80% | |
| Acelyrin | 77% |
Lirum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 11, 2024 | ||||
| Private Placement | Feb 8, 2023 |
Lirum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lirum Therapeutics's valuation, stock price, and market status.
Is Lirum Therapeutics a public or private company?
Lirum Therapeutics is a private company.
What is the current stock price of Lirum Therapeutics?
Lirum Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Lirum Therapeutics worth (valuation)?
Lirum Therapeutics's valuation is estimated at $45.0M based on funding round data.
Can I buy Lirum Therapeutics stock?
Lirum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lirum Therapeutics's last funding round?
Lirum Therapeutics's most recent funding round was IPO on March 11, 2024.
Who are the main investors in Lirum Therapeutics?
Investor information for Lirum Therapeutics is not publicly disclosed.
Will Lirum Therapeutics IPO soon?
No public IPO plans have been announced for Lirum Therapeutics.
How can I track Lirum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lirum Therapeutics's secondary market activity and sign up for updates.